Bipolar Decision Tree

USW1.3278.202230 - DNRS-6630A-4/NURS-6630F-4/NURS-6630N-4/NURS-6630C-4/DNRS-6630-4-APPROACHES TO TREATMENT-2021-WINTER-QTR-TERM-WKS-1-THRU-11-(11/29/2021- 02/13/2022)-PT27

SafeAssign Drafts Monique Moise on Sun, Jan 02 2022, 10:49 PM 100% highest match Submission ID: 96c20a33-99d0-4ec8-a845-4add53229e3c

Attachments (1)

WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx Running head: 1 PATIENT WITH BIPOLAR DISORDER 2

PATIENT WITH BIPOLAR DISORDER 2

ASSESSING AND TREATING PATIENTS WITH BIPOLAR DISORDER

Monique Moise

Walden University

NURS6630

January 01, 2022

1 BIPOLAR DISORDER IS A MENTAL HEALTH DISORDER CHARACTERIZED THROUGH EXTREME MOOD SHIFTS THAT RANGE FROM MANIA TO DEPRESSION. SOMETIMES PATIENTS EXPERIENCE BOTH MANIA AND DEPRESSION. MANIA IS WHEN THE PATIENTS’ BEHAVIOR IS ELATED AND ENERGIZED WHILE DEPRESSION IS WHEN THE PATIENT IS SAD, FEELS INDIFFERENT AND HOPELESS (CARVALHO, 2020).

IN THIS CASE STUDY, THE PATIENT IS A 26-YEAR-OLD WOMAN OF KOREAN DESCENT, WHO ON HER FIRST APPOINTMENT AFTER 21 DAYS OF HOSPITALIZATION HAS AN ONSET OF ACUTE MANIA. THE PATIENT HAS BIPOLAR DISORDER. THE SPECIFIC PATIENT CHARACTERISTICS THAT WILL INFLUENCE MY DECISION BEFORE PRESCRIBING ANY MEDICATIONS INCLUDE THE PATIENT'S HYPERACTIVITY. UPON ARRIVAL AT THE OFFICE, THE PATIENT APPEARS TO BE QUITE BUSY. SHE CONSTANTLY PLAYS WITH THINGS ON THE DESK AND SHIFTS FROM SIDE TO SIDE IN HER SEAT. ANOTHER FACTOR THAT WOULD INFLUENCE MY DECISION IS THAT THE PATIENTS LACK OF INSIGHT OF HER DISEASE. SHE SAYS THAT SHE HAS BEEN INFORMED THAT SHE HAS BIPOLAR,

(http://safeassign.blackboard.com/)

WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx Word Count: 1,528 Attachment ID: 5116148183

100%

BUT SHE DOESN’T BELIEVE IT. SHE ALSO HAS FLIGHT OF IDEAS.

ON REVIEWING HER MEDICAL RECORDS, SHE HAD BEEN SEEN BY A PHYSICIAN WHO REPORTED HER TO BE IN GOOD HEALTH. ALL THE LAB WORKS WERE WITHIN NORMAL LIMITS. THE PATIENT HAD ALSO UNDERGONE GENETIC TESTING IN THE HOSPITAL BECAUSE NONE OF HER MEDICATIONS SEEMED TO WORK. 2 SHE ALSO TESTED POSITIVE FOR CYP2D6 10 ALLELE. 1 THE POSITIVE RESULTS WOULD ALSO INFLUENCE THE DECISION ON WHICH MEDICATION WOULD BE PRESCRIBED FOR THE PATIENT. THE PATIENT ALSO CONFESSED TO HAVING STOPPED TAKING THE LITHIUM THAT WAS PRESCRIBED TO HER TWO WEEKS AGO.

ON PERFORMING A MENTAL STATUS EXAM, THE PATIENT IS ALERT, ORIENTED TO PERSON, PLACE, TIME AND EVENT. HER SPEECH IS RAPID, PRESSURED, AND TANGENTIAL. SELF-REPORTED MOOD IS EUTHYMIC. AFFECT IS BROAD. SHE DOES NOT HAVE VISUAL OR AUDITORY HALLUCINATIONS. SHE HAS NO DELUSIONS, AND THE THOUGHT PROCESS IS APPARENT. JUDGEMENT IS INTACT AND SHE HAS NO SUICIDAL OR HOMICIDAL THOUGHTS. 3 WHEN GIVEN THE YOUNG MANIA RATING SCALE, HER SCORE WAS 22.

Decision # 1

1 BEGIN THE PATIENT ON LITHIUM 300MG. Lithium is a mood stabilizer that is recommended as a first line of defense when managing acute mania. 1 LITHIUM ACTS BY DOWNREGULATING THE NMDA RECEPTORS. NMDA RECEPTORS ARE ION CHANNEL AND GLUTAMATE PROTEIN RECEPTORS. ONCE THEY ARE DOWNREGULATED, THE LEVELS OF GLUTAMATE IN THE POSTSYNAPTIC NEURONS INCREASE WHILE DECREASING IN THE PRESYNAPTIC NEURONS. GLUTAMATE IS AN EXCITATORY NEUROTRANSMITTER. DURING MANIA, THE LEVELS OF GLUTAMATE ARE ELEVATED. A DECREASE OF GLUTAMATE IN THE PRESYNAPTIC NEURONS REDUCE THE EXCITATORY EFFECT THAT IS CAUSED BY GLUTAMATE. LITHIUM ALSO CAUSES A DECREASE OF DOPAMINE ACTIVITY IN THE PRESYNAPTIC NEURONS. THIS ALSO REDUCES THE EXCITATORY NEUROTRANSMISSION IN THE BRAIN, LEADING TO A RESOLUTION OF THE MANIC EPISODES (MALHI, 2017).

APART FROM LITHIUM BEING THE FIRST LINE OF TREATMENT FOR BIPOLAR DISORDERS, I ALSO CHOSE LITHIUM BECAUSE OF ITS PHARMACOKINETICS. LITHIUM WORKS RAPIDLY AND COMPLETELY ABSORBS. IT HAS A PEAK SERUM CONCENTRATION OF 1 TO 2 HOURS. MOST OF THE LITHIUM IS EXCRETED IN URINE WITH FEW AMOUNTS EXCRETED IN FECES AND SWEAT. IT HAS A HALF-LIFE OF 24 HOURS AND A BIOAVAILABILITY OF UP TO 5 DAYS.

I DID NOT CHOOSE RISPERIDAL 1 MG AND SEROQUEL XR 100MG BECAUSE THE PATIENT TESTED POSITIVE OF CYTOCHROME CYP2D6 10 ALLELE. RISPERIDAL AND SEROQUEL XR ARE METABOLIZED BY THE ENZYME CYP2D6 IN THE LIVER INTO THEIR ACTIVE METABOLITES WHILE LITHIUM IS NOT AFFECTED BY THIS ENZYME. ONCE A DRUG HAS BEEN METABOLIZED, ITS THERAPEUTIC EFFECT DECREASES (LOPEZ-MUNOZ, 2018). BY SELECTING LITHIUM, I WAS HOPING TO CALM THE PATIENT WITHIN A FEW HOURS. THIS IS BECAUSE LITHIUM HAS A PEAK PLASMA CONCENTRATION OF 2 HOURS (MALHI, 2017). BY SELECTING LITHIUM, I WAS HOPING TO CALM THE PATIENT WITHIN A FEW HOURS. THIS IS BECAUSE LITHIUM HAS A PEAK PLASMA

CONCENTRATION OF 2 HOURS (MALHI, 2017).

ETHICAL CONSIDERATIONS SUCH AS AUTONOMY AND RESPECT MAY IMPACT MY TREATMENT PLAN AND COMMUNICATION WITH PATIENT. IN AUTONOMY, THE PATIENT MIGHT REFUSE MY CHOICE OF MEDICATION, AND THIS MIGHT NEGATIVELY IMPACT MY TREATMENT PLAN. THE PATIENT SHOULD BE COMMUNICATED TO WITH RESPECT.

Decision #2

For the second decision the dosage is increased from 300 mgs to 450 mgs. 1 THE DOSAGE WAS INCREASED BECAUSE THE PATIENT WAS STILL EXPERIENCING THE SAME SYMPTOMS THAT SHE HAD EXPERIENCED TWO WEEKS AGO. PATIENT ALSO REPORTS THAT SHE HAS BEEN ON AND OFF LITHIUM. THE RATIONALE BEHIND NON-COMPLIANCE WAS THE LACK OF INSIGHT. The patient has been told that she has bipolar disorder but doesn’t believe that she has it. 1 THE PATIENT ALSO STATES THAT THE DRUGS MAKE HER FEEL NAUSEATED AND GIVES HER DIARRHEA. WHEN SHE TAKES THE MEDICATION HER PHYSICAL SYMPTOMS ARE PRESENT AND WHEN SHE STOPS TAKING HER MEDICATION THE PHYSICAL SYMPTOMS ABATE. THE PATIENT IS SWITCHED TO DEPAKOTE 500 MGS ORALLY. THIS IS BECAUSE DEPAKOTE HAS LESSER SIDE EFFECTS (TONDO, 2017).

THE PATIENT IS EDUCATED ON THE EFFECTS OF NOT COMPLYING WITH THE TREATMENTS. IF SHE IS NOT COMPLIANT WITH THE MEDICATIONS, IT MIGHT WORSEN THE SYMPTOMS OF THE BIPOLAR. SHE IS ALSO AT A RISK OF DEVELOPING RESISTANCE TO THE DRUG WHEREBY WHENEVER SHE WILL BE TAKING THE DRUG IT MIGHT NOT HAVE ANY EFFECT. NON-COMPLIANCY CAN ALSO LEAD TO ADVERSE EFFECTS OF LITHIUM WHICH INCLUDE TREMORS, INCREASE IN CREATININE LEVELS, WEIGHT GAIN AND DIABETES INSIPIDUS (PETRO, 2020).

THE ETHICAL CONSIDERATIONS THAT MAY IMPACT THE TREATMENT PLAN ON HOW TO COMMUNICATE WITH THE CLIENT AT THIS POINT INCLUDES INFORMED CONSENT, RESPECT AND NON-MALEFICENCE. WHEN THE PATIENT HAS BEEN FULLY INFORMED OF THE SIDE EFFECTS OF NOT ADHERING TO THE TREATMENT, THIS KNOWLEDGE MAY INFLUENCE THEIR DECISION ON FOLLOWING THE TREATMENT REGIMEN. IN NON-MALEFICENCE, THE DRUGS SHOULD NOT CAUSE HARM TO THE PATIENT. THIS DECISION WILL IMPACT THE TREATMENT PLAN AND WOULD LEAD TO THE NEED TO CHANGE THE MEDICATION IF THE PATIENT CANNOT TOLERATE LITHIUM. THE PATIENT SHOULD BE INFORMED ALL OF THESE WITH RESPECT.

Decision #3

1 TO CHANGE THE LITHIUM MEDICATION TO A SUSTAINED RELEASE AT THE SAME DOSE AND FREQUENCY. SINCE THE PATIENT IS EXPERIENCING NAUSEA AND DIARRHEA WHICH ARE THE CLASSIC SYMPTOMS OF LITHIUM THERAPY, CHANGING THE PATIENT TO AN EXTENDED-RELEASE FORMULATION CAN PREVENT THESE SYMPTOMS FROM OCCURRING AND AT THE SAME TIME CAN BENEFIT THE PATIENT'S MOOD STABILIZING PROPERTIES TO LITHIUM. ANOTHER REASON FOR USING SUSTAINED RELEASE IS THAT LITHIUM IS A GOOD CHOICE FOR THE MANAGEMENT OF MANIA AND ADDING TO ITS BENEFITS, IT ALSO DECREASES THE CHANCES FOR SUICIDE (MALHI,

2017).

DEPAKOTE MAY BE ANOTHER OPTION IF CHANGING TO SUSTAINED RELEASE FORMULATION OF LITHIUM DOES NOT HELP ALLEVIATE THE SYMPTOMS. OXCARBAZEPINE CAN ALSO BE AN OPTION, BUT IT IS A SECOND LINE THERAPY, AND IT IS NOT APPROPRIATE FOR THIS PATIENT BECAUSE SHE HAS NOT HAD AN ADEQUATE TRIAL OF FIRST LINE AGENTS (BOJIC, 2017). THE PATIENT HAS NOT BEEN COMPLIANT WITH TAKING HER LITHIUM MEDICATIONS SO SECOND LINE AGENTS CANNOT BE ADMINISTERED, ESPECIALLY IF WE ARE NOT SURE IF THE LITHIUM CAN RESOLVE THE PATIENTS' symptoms.

1 ETHICAL CONSIDERATIONS WHILE CHANGING THE PATIENT’S MEDICATION IS NON MALEFICENCE AND AUTONOMY. THE SUSTAINED RELEASE FORMULATION OF LITHIUM SHOULD NOT CAUSE ANY HARM TO THE PATIENT. The patient also has the right to make decisions of changing their medication. 1 ALL INFORMATION REGARDING THE NEW FORMULATIONS OR MEDICATIONS SHOULD BE COMMUNICATED TO THE PATIENT. THIS WILL HAVE AN IMPACT ON THE TREATMENT PLAN BECAUSE THE PATIENT WILL BE ABLE TO MAKE AN INFORMED CHOICE.

Conclusion

1 IN CONCLUSION, LITHIUM IS THE BEST CHOICE IN THE MANAGEMENT OF BIPOLAR DISORDER. IT ACTS IN THE CENTRAL NERVOUS SYSTEM AND DECREASES THE LEVELS OF THE EXCITATORY HORMONES RESPONSIBLE FOR MANIC EPISODES OF BIPOLAR. LITHIUM IS ALSO RECOMMENDED FOR THIS PATIENT BECAUSE IT IS NOT METABOLIZED BY ENZYME CYTOCHROME CYP2D6. NONADHERENCE TO LITHIUM THERAPY MAY AGGRAVATE THE SYMPTOMS OF BIPOLAR. IN ALLEVIATING THE SIDE EFFECTS OF LITHIUM, AN EXTENDED-RELEASE FORMULATION OF LITHIUM CAN BE ADMINISTERED. DEPAKOTE CAN ALSO BE USED AS AN ALTERNATIVE MEDICINE FOR LITHIUM. ETHICAL CONSIDERATIONS THAT MAY IMPACT TREATMENT PLAN AND COMMUNICATION INCLUDE RESPECT, AUTONOMY, AND NON-MALEFICENCE.

References

1 BOJIC, S., & BECERRA, R. (2017). 1 MINDFULNESS-BASED TREATMENT FOR BIPOLAR DISORDER: A SYSTEMATIC REVIEW OF THE LITERATURE. EUROPE'S JOURNAL OF PSYCHOLOGY, 13(3), 573.

Carvalho, A. 1 F., FIRTH, J., & VIETA, E. (2020). Bipolar disorder. 1 NEW ENGLAND JOURNAL OF MEDICINE, 383(1), 58-66.

DePetro, E. (2020). 1 MEDICATION NON-COMPLIANCE: COMPLIANCE TO PSYCHOTROPIC MEDICATIONS WITHIN COMMUNITY MENTAL HEALTH.

LÓPEZ-MUÑOZ, F., SHEN, W. W., D’OCON, P., ROMERO, A., & ÁLAMO, C. (2018). 1 A HISTORY OF THE PHARMACOLOGICAL TREATMENT OF BIPOLAR DISORDER. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19(7), 2143.

Malhi, G. 1 S., GESSLER, D., & OUTHRED, T. (2017). 1 THE USE OF LITHIUM FOR THE TREATMENT OF

BIPOLAR DISORDER: RECOMMENDATIONS FROM CLINICAL PRACTICE GUIDELINES. JOURNAL OF AFFECTIVE DISORDERS, 217, 266-280.

TONDO, L., ABRAMOWICZ, M., ALDA, M., BAUER, M., BOCCHETTA, A., BOLZANI, L.,. & Baldessarini, R. J. (2017). 1 LONG-TERM LITHIUM TREATMENT IN BIPOLAR DISORDER: EFFECTS ON GLOMERULAR FILTRATION RATE AND OTHER METABOLIC PARAMETERS. INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 5(1), 1-12.

Citations (3/3)

Matched Text

1 Another student's paper

2 Another student's paper

3 Another student's paper

Suspected Entry: 69% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx PATIENT WITH BIPOLAR DISORDER 2

Source - Another student's paper The patient has bipolar disorder

Suspected Entry: 69% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx PATIENT WITH BIPOLAR DISORDER 2

Source - Another student's paper The patient has bipolar disorder

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ASSESSING AND TREATING PATIENTS WITH BIPOLAR DISORDER

Source - Another student's paper Assessing and Treating Patients with Bipolar Disorder

Suspected Entry: 92% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx BIPOLAR DISORDER IS A MENTAL HEALTH DISORDER CHARACTERIZED THROUGH EXTREME MOOD SHIFTS THAT RANGE FROM MANIA TO DEPRESSION

Source - Another student's paper Bipolar is a mental health disorder characterized with extreme mood shifts that range from mania to depression

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SOMETIMES PATIENTS EXPERIENCE BOTH MANIA AND DEPRESSION

Source - Another student's paper Sometimes patients experience both mania and depression

Suspected Entry: 86% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx MANIA IS WHEN THE PATIENTS’ BEHAVIOR IS ELATED AND ENERGIZED WHILE DEPRESSION IS WHEN THE PATIENT IS SAD, FEELS INDIFFERENT AND HOPELESS (CARVALHO, 2020)

Source - Another student's paper Mania is when the patients` behaviors are elated and energized while depression is when the patient is sad, feels indifferent and hopeless (Carvalho, 2020)

Suspected Entry: 97% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IN THIS CASE STUDY, THE PATIENT IS A 26-YEAR-OLD WOMAN OF KOREAN DESCENT, WHO ON HER FIRST APPOINTMENT AFTER 21 DAYS OF HOSPITALIZATION HAS AN ONSET OF ACUTE MANIA

Source - Another student's paper In this case study, the patient is a 26-year-old woman with a Korean descent, who on her first appointment after 21 days of hospitalization has an onset of acute mania

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT HAS BIPOLAR DISORDER

Source - Another student's paper The patient has bipolar disorder

Suspected Entry: 78% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE SPECIFIC PATIENT CHARACTERISTICS THAT WILL INFLUENCE MY DECISION BEFORE PRESCRIBING ANY MEDICATIONS INCLUDE THE PATIENT'S HYPERACTIVITY

Source - Another student's paper The specific patient characteristics that will influence my decision before prescribing medications include the patient being hyperactive

Suspected Entry: 85% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx UPON ARRIVAL AT THE OFFICE, THE PATIENT APPEARS TO BE QUITE BUSY

Source - Another student's paper Upon arrival at the office, the patient is quite busy

Suspected Entry: 82% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SHE CONSTANTLY PLAYS WITH THINGS ON THE DESK AND SHIFTS FROM SIDE TO SIDE IN HER SEAT

Source - Another student's paper She plays with things on the desk and she shifts from side to side in her desk

Suspected Entry: 75% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ANOTHER FACTOR THAT WOULD INFLUENCE MY DECISION IS THAT THE PATIENTS LACK OF INSIGHT OF HER DISEASE

Source - Another student's paper Another factor that will influence my decision is that the patient lacks insight of her disease

Suspected Entry: 76% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SHE SAYS THAT SHE HAS BEEN INFORMED THAT SHE HAS BIPOLAR, BUT SHE DOESN’T BELIEVE IT

Source - Another student's paper She says that she was informed that she has bipolar but she doesn`t believe that

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SHE ALSO HAS FLIGHT OF IDEAS

Source - Another student's paper She also has flight of ideas

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ON REVIEWING HER MEDICAL RECORDS, SHE HAD BEEN SEEN BY A PHYSICIAN WHO REPORTED HER TO BE IN GOOD HEALTH

Source - Another student's paper On reviewing her medical records, she had been seen by a physician who reported her to be in good health

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ALL THE LAB WORKS WERE WITHIN NORMAL LIMITS

Source - Another student's paper All the lab works were within normal limits

Suspected Entry: 78% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT HAD ALSO UNDERGONE GENETIC TESTING IN THE HOSPITAL BECAUSE NONE OF HER MEDICATIONS SEEMED TO WORK

Source - Another student's paper The patient had also undergone genetic testing in the hospital because none of her medications seemed to work and she tested positive for CYP2D6 10 allele

Suspected Entry: 63% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE POSITIVE RESULTS WOULD ALSO INFLUENCE THE DECISION ON WHICH MEDICATION WOULD BE PRESCRIBED FOR THE PATIENT

Source - Another student's paper This will also influence the decision on medication for the patient

Suspected Entry: 87% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT ALSO CONFESSED TO HAVING STOPPED TAKING THE LITHIUM THAT WAS PRESCRIBED TO HER TWO WEEKS AGO

Source - Another student's paper Patient also confessed to have stopped taking lithium which was prescribed for her two weeks ago

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ON PERFORMING A MENTAL STATUS EXAM, THE PATIENT IS ALERT, ORIENTED TO PERSON, PLACE, TIME AND EVENT

Source - Another student's paper On performing a mental status exam, the patient is alert, oriented to person, place, time and event

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx HER SPEECH IS RAPID, PRESSURED, AND TANGENTIAL

Source - Another student's paper Her speech is rapid, pressured and tangential

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SELF-REPORTED MOOD IS EUTHYMIC

Source - Another student's paper Self-reported mood is euthymic

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx AFFECT IS BROAD

Source - Another student's paper Affect is broad

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SHE DOES NOT HAVE VISUAL OR AUDITORY HALLUCINATIONS

Source - Another student's paper She does not have visual or auditory hallucinations

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SHE HAS NO DELUSIONS, AND THE THOUGHT PROCESS IS APPARENT

Source - Another student's paper She has no delusions, and the thought process is apparent

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx JUDGEMENT IS INTACT AND SHE HAS NO SUICIDAL OR HOMICIDAL THOUGHTS

Source - Another student's paper Judgement is intact and she has no suicidal or homicidal thoughts

Suspected Entry: 79% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx BEGIN THE PATIENT ON LITHIUM 300MG

Source - Another student's paper Begin Lithium 300mg

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx LITHIUM ACTS BY DOWNREGULATING THE NMDA RECEPTORS

Source - Another student's paper Lithium acts by downregulating the NMDA receptors

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx NMDA RECEPTORS ARE ION CHANNEL AND GLUTAMATE PROTEIN RECEPTORS

Source - Another student's paper NMDA receptors are ion channel and glutamate protein receptors

Suspected Entry: 83% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ONCE THEY ARE DOWNREGULATED, THE LEVELS OF GLUTAMATE IN THE POSTSYNAPTIC NEURONS INCREASE WHILE DECREASING IN THE PRESYNAPTIC NEURONS

Source - Another student's paper Once they are downregulated, the levels of glutamate in the postsynaptic neurons increases while it decreases in the presynaptic neurons

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx GLUTAMATE IS AN EXCITATORY NEUROTRANSMITTER

Source - Another student's paper Glutamate is an excitatory neurotransmitter

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx DURING MANIA, THE LEVELS OF GLUTAMATE ARE ELEVATED

Source - Another student's paper During mania, the levels of glutamate are elevated

Suspected Entry: 87% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx A DECREASE OF GLUTAMATE IN THE PRESYNAPTIC NEURONS REDUCE THE EXCITATORY EFFECT THAT IS CAUSED BY GLUTAMATE

Source - Another student's paper A decrease of glutamate in the presynaptic neurons, reduces the excitatory effect caused by glutamate

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx LITHIUM ALSO CAUSES A DECREASE OF DOPAMINE ACTIVITY IN THE PRESYNAPTIC NEURONS

Source - Another student's paper Lithium also causes a decrease of dopamine activity in the presynaptic neurons

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THIS ALSO REDUCES THE EXCITATORY NEUROTRANSMISSION IN THE BRAIN, LEADING TO A RESOLUTION OF THE MANIC

Source - Another student's paper This also reduces the excitatory neurotransmission in the brain, leading to a resolution of the manic episodes (Malhi, 2017)

EPISODES (MALHI, 2017)

Suspected Entry: 96% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx APART FROM LITHIUM BEING THE FIRST LINE OF TREATMENT FOR BIPOLAR DISORDERS, I ALSO CHOSE LITHIUM BECAUSE OF ITS PHARMACOKINETICS

Source - Another student's paper Apart from lithium being the first line of treatment for bipolar, I also chose lithium because of its pharmacokinetics

Suspected Entry: 62% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx LITHIUM WORKS RAPIDLY AND COMPLETELY ABSORBS

Source - Another student's paper Lithium is rapidly and completely absorbed

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IT HAS A PEAK SERUM CONCENTRATION OF 1 TO 2 HOURS

Source - Another student's paper It has a peak serum concentration of 1 to 2 hours

Suspected Entry: 94% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx MOST OF THE LITHIUM IS EXCRETED IN URINE WITH FEW AMOUNTS EXCRETED IN FECES AND SWEAT

Source - Another student's paper Most of the lithium is excreted in urine with few amounts in feces and sweat

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IT HAS A HALF-LIFE OF 24 HOURS AND A BIOAVAILABILITY OF UP TO 5 DAYS

Source - Another student's paper It has a half-life of 24 hours and a bioavailability of up to 5 days

Suspected Entry: 93% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx I DID NOT CHOOSE RISPERIDAL 1 MG AND SEROQUEL XR 100MG BECAUSE THE PATIENT TESTED POSITIVE OF CYTOCHROME CYP2D6 10 ALLELE

Source - Another student's paper I did not choose Risperdal 1 mg and Seroquel XR 100mg because the patient tested positive of cytochrome CYP2D6 10 allele

Suspected Entry: 94% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx RISPERIDAL AND SEROQUEL XR ARE METABOLIZED BY THE ENZYME CYP2D6 IN THE LIVER INTO THEIR ACTIVE METABOLITES WHILE LITHIUM IS NOT AFFECTED BY THIS ENZYME

Source - Another student's paper Risperdal and Seroquel XR are metabolized by the enzyme CYP2D6 in the liver into their active metabolites while lithium is not affected by this enzyme

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ONCE A DRUG HAS BEEN METABOLIZED, ITS THERAPEUTIC EFFECT DECREASES (LOPEZ-MUNOZ, 2018)

Source - Another student's paper Once a drug has been metabolized, its therapeutic effect decreases (Lopez-Munoz, 2018)

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx BY SELECTING LITHIUM, I WAS HOPING TO CALM THE PATIENT WITHIN A FEW HOURS

Source - Another student's paper By selecting Lithium, I was hoping to calm the patient within a few hours

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THIS IS BECAUSE LITHIUM HAS A PEAK PLASMA CONCENTRATION OF 2 HOURS (MALHI, 2017)

Source - Another student's paper This is because lithium has a peak plasma concentration of 2 hours (Malhi, 2017)

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx BY SELECTING LITHIUM, I WAS HOPING TO CALM THE PATIENT WITHIN A FEW HOURS

Source - Another student's paper By selecting Lithium, I was hoping to calm the patient within a few hours

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THIS IS BECAUSE LITHIUM HAS A PEAK PLASMA CONCENTRATION OF 2 HOURS (MALHI, 2017)

Source - Another student's paper This is because lithium has a peak plasma concentration of 2 hours (Malhi, 2017)

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ETHICAL CONSIDERATIONS SUCH AS AUTONOMY AND RESPECT MAY IMPACT MY TREATMENT PLAN AND COMMUNICATION WITH PATIENT

Source - Another student's paper Ethical considerations such as autonomy and respect may impact my treatment plan and communication with patient

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IN AUTONOMY, THE PATIENT MIGHT REFUSE MY CHOICE OF MEDICATION, AND THIS MIGHT NEGATIVELY IMPACT MY TREATMENT PLAN

Source - Another student's paper In autonomy, the patient might refuse my choice of medication and this might negatively impact my treatment plan

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT SHOULD BE COMMUNICATED TO WITH RESPECT

Source - Another student's paper The patient should be communicated to with respect

Suspected Entry: 67% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE DOSAGE WAS INCREASED BECAUSE THE PATIENT WAS STILL EXPERIENCING THE SAME SYMPTOMS THAT SHE HAD EXPERIENCED TWO WEEKS AGO

Source - Another student's paper This is because the patient still presents with the same symptoms, she had two weeks ago

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx PATIENT ALSO REPORTS THAT SHE HAS BEEN ON AND OFF LITHIUM

Source - Another student's paper Patient also reports that she has been on and off lithium

Suspected Entry: 73% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE RATIONALE BEHIND NON-COMPLIANCE WAS THE LACK OF INSIGHT

Source - Another student's paper The rationale behind noncompliance was the lack of insight

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT ALSO STATES THAT THE DRUGS MAKE HER FEEL NAUSEATED AND GIVES HER DIARRHEA

Source - Another student's paper The patient also states that the drugs make her feel nauseated and gives her diarrhea

Suspected Entry: 64% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx WHEN SHE TAKES THE MEDICATION HER PHYSICAL SYMPTOMS ARE PRESENT AND WHEN SHE STOPS TAKING HER MEDICATION THE PHYSICAL SYMPTOMS ABATE

Source - Another student's paper When she stops taking the medicine, the symptoms abate, and when she starts taking the medication, the symptoms start again

Suspected Entry: 72% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT IS SWITCHED TO DEPAKOTE 500 MGS ORALLY

Source - Another student's paper The patient is switched to Depakote 500mgs orally

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THIS IS BECAUSE DEPAKOTE HAS LESSER SIDE EFFECTS

Source - Another student's paper This is because Depakote has lesser side effects (Tondo, 2017)

(TONDO, 2017)

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT IS EDUCATED ON THE EFFECTS OF NOT COMPLYING WITH THE TREATMENTS

Source - Another student's paper The patient is educated on the effects of not complying with the treatments

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IF SHE IS NOT COMPLIANT WITH THE MEDICATIONS, IT MIGHT WORSEN THE SYMPTOMS OF THE BIPOLAR

Source - Another student's paper If she is not compliant with the medications, it might worsen the symptoms of the Bipolar

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SHE IS ALSO AT A RISK OF DEVELOPING RESISTANCE TO THE DRUG WHEREBY WHENEVER SHE WILL BE TAKING THE DRUG IT MIGHT NOT HAVE ANY EFFECT

Source - Another student's paper She is also at a risk of developing resistance to the drug whereby whenever she will be taking the drug it might not have any effect

Suspected Entry: 94% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx NON-COMPLIANCY CAN ALSO LEAD TO ADVERSE EFFECTS OF LITHIUM WHICH INCLUDE TREMORS, INCREASE IN CREATININE LEVELS, WEIGHT GAIN AND DIABETES INSIPIDUS (PETRO, 2020)

Source - Another student's paper Non-compliance can also lead to adverse effects of lithium which include tremors, increase in creatinine levels, weight gain and diabetes insipidus (Petro, 2020)

Suspected Entry: 93% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE ETHICAL CONSIDERATIONS THAT MAY IMPACT THE TREATMENT PLAN ON HOW TO COMMUNICATE WITH THE CLIENT AT THIS POINT INCLUDES INFORMED CONSENT, RESPECT AND NON-MALEFICENCE

Source - Another student's paper The ethical considerations that may impact the treatment plan and how to communicate with the client at this point include informed consent, respect and non-maleficence

Suspected Entry: 89% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx WHEN THE PATIENT HAS BEEN FULLY INFORMED OF THE SIDE EFFECTS OF NOT ADHERING TO THE TREATMENT, THIS KNOWLEDGE MAY INFLUENCE THEIR DECISION ON FOLLOWING THE TREATMENT REGIMEN

Source - Another student's paper When the patient has been fully informed of the side effects of not adhering to the treatment, they may influence their decisions on following the treatment regimen

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IN NON-MALEFICENCE, THE DRUGS SHOULD NOT CAUSE HARM TO THE PATIENT

Source - Another student's paper In non-maleficence, the drugs should not cause harm to the patient

Suspected Entry: 78% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THIS DECISION WILL IMPACT THE TREATMENT PLAN AND WOULD LEAD TO THE NEED TO CHANGE THE MEDICATION IF THE PATIENT CANNOT TOLERATE LITHIUM

Source - Another student's paper This decision will impact the treatment plan and will have to change the medications if the patient cannot tolerate lithium

Suspected Entry: 98% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT SHOULD BE INFORMED ALL OF THESE WITH RESPECT

Source - Another student's paper The patient should be informed all these with respect

Suspected Entry: 93% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx TO CHANGE THE LITHIUM MEDICATION TO A SUSTAINED RELEASE AT THE SAME DOSE AND FREQUENCY

Source - Another student's paper To change Lithium to a sustained release at same dose and frequency

Suspected Entry: 93% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SINCE THE PATIENT IS EXPERIENCING NAUSEA AND DIARRHEA WHICH ARE THE CLASSIC SYMPTOMS OF LITHIUM THERAPY, CHANGING THE PATIENT TO AN EXTENDED-RELEASE FORMULATION CAN PREVENT THESE SYMPTOMS FROM OCCURRING AND AT THE SAME TIME CAN BENEFIT THE PATIENT'S MOOD STABILIZING PROPERTIES TO LITHIUM

Source - Another student's paper Since the patient is experiencing nausea and diarrhea which are the classic symptoms of lithium therapy, changing the patient to an extended-release formulation can prevent these symptoms from occurring and at the same time the patient will benefit from lithium`s mood stabilizing properties

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ANOTHER REASON FOR USING SUSTAINED RELEASE IS THAT LITHIUM IS A GOOD CHOICE FOR THE MANAGEMENT OF MANIA AND ADDING TO ITS BENEFITS, IT ALSO DECREASES THE CHANCES FOR SUICIDE (MALHI, 2017)

Source - Another student's paper Another reason for using sustained release is that lithium is a good choice for the management of mania and adding to its benefits, it also decreases the chances for suicide (Malhi, 2017)

Suspected Entry: 92% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx DEPAKOTE MAY BE ANOTHER OPTION IF CHANGING TO SUSTAINED RELEASE FORMULATION OF LITHIUM DOES NOT HELP ALLEVIATE THE SYMPTOMS

Source - Another student's paper Depakote may be an option if changing to sustained release formulation of lithium does not alleviate the symptoms

Suspected Entry: 98% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx OXCARBAZEPINE CAN ALSO BE AN OPTION, BUT IT IS A SECOND LINE THERAPY, AND IT IS NOT APPROPRIATE FOR THIS PATIENT BECAUSE SHE HAS NOT HAD AN ADEQUATE TRIAL OF FIRST LINE AGENTS (BOJIC, 2017)

Source - Another student's paper Oxcarbazepine can also be an option but it is a second line therapy and it is not appropriate for this patient because she has not had adequate trial of the first line agents (Bojic, 2017)

Suspected Entry: 80% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE PATIENT HAS NOT BEEN COMPLIANT WITH TAKING HER LITHIUM MEDICATIONS SO SECOND LINE AGENTS CANNOT BE ADMINISTERED, ESPECIALLY IF WE ARE NOT SURE IF THE LITHIUM CAN RESOLVE THE PATIENTS&APOS

Source - Another student's paper The patient has not been compliant with taking her lithium medications so second line agents cannot be given especially if we are not sure if lithium could have resolved the patient`s symptoms

Suspected Entry: 86% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ETHICAL CONSIDERATIONS WHILE CHANGING THE PATIENT’S MEDICATION IS NON MALEFICENCE AND AUTONOMY

Source - Another student's paper Ethical considerations while changing the patient`s medication is non maleficence and autonomy

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE SUSTAINED RELEASE FORMULATION OF LITHIUM SHOULD NOT CAUSE ANY HARM TO THE PATIENT

Source - Another student's paper The sustained release formulation of lithium should not cause any harm to the patient

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ALL INFORMATION REGARDING THE NEW FORMULATIONS OR MEDICATIONS SHOULD BE COMMUNICATED TO THE PATIENT

Source - Another student's paper All information regarding the new formulations or medications should be communicated to the patient

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THIS WILL HAVE AN IMPACT ON THE TREATMENT PLAN BECAUSE THE PATIENT WILL BE ABLE TO MAKE AN INFORMED CHOICE

Source - Another student's paper This will have an impact on the treatment plan because the patient will be able to make an informed choice

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IN CONCLUSION, LITHIUM IS THE BEST CHOICE IN THE MANAGEMENT OF BIPOLAR DISORDER

Source - Another student's paper In conclusion, lithium is the best choice in the management of bipolar disorder

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IT ACTS IN THE CENTRAL NERVOUS SYSTEM AND DECREASES THE LEVELS OF THE EXCITATORY HORMONES RESPONSIBLE FOR MANIC EPISODES OF BIPOLAR

Source - Another student's paper It acts in the central nervous system and decreases the levels of the excitatory hormones responsible for manic episodes of bipolar

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx LITHIUM IS ALSO RECOMMENDED FOR THIS PATIENT BECAUSE IT IS NOT METABOLIZED BY ENZYME CYTOCHROME CYP2D6

Source - Another student's paper Lithium is also recommended for this patient because it is not metabolized by enzyme cytochrome CYP2D6

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx NONADHERENCE TO LITHIUM THERAPY MAY AGGRAVATE THE SYMPTOMS OF BIPOLAR

Source - Another student's paper Nonadherence to lithium therapy may aggravate the symptoms of Bipolar

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx IN ALLEVIATING THE SIDE EFFECTS OF LITHIUM, AN EXTENDED- RELEASE FORMULATION OF LITHIUM CAN BE ADMINISTERED

Source - Another student's paper In alleviating the side effects of lithium, an extended-release formulation of lithium can be administered

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx DEPAKOTE CAN ALSO BE USED AS AN ALTERNATIVE MEDICINE FOR LITHIUM

Source - Another student's paper Depakote can also be used as an alternative medicine for lithium

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx ETHICAL CONSIDERATIONS THAT MAY IMPACT TREATMENT PLAN AND COMMUNICATION INCLUDE RESPECT, AUTONOMY, AND NON-MALEFICENCE

Source - Another student's paper Ethical considerations that may impact treatment plan and communication include respect, autonomy and non-maleficence

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx BOJIC, S., & BECERRA, R

Source - Another student's paper Bojic, S., & Becerra, R

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx MINDFULNESS-BASED TREATMENT FOR BIPOLAR DISORDER

Source - Another student's paper Mindfulness-based treatment for bipolar disorder

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx A SYSTEMATIC REVIEW OF THE LITERATURE

Source - Another student's paper A systematic review of the literature

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx EUROPE'S JOURNAL OF PSYCHOLOGY, 13(3), 573

Source - Another student's paper Europe's journal of psychology, 13(3), 573

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx F., FIRTH, J., & VIETA, E

Source - Another student's paper F., Firth, J., & Vieta, E

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx NEW ENGLAND JOURNAL OF MEDICINE, 383(1), 58-66

Source - Another student's paper New England Journal of Medicine, 383(1), 58-66

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx MEDICATION NON-COMPLIANCE

Source - Another student's paper Medication non-compliance

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx COMPLIANCE TO PSYCHOTROPIC MEDICATIONS WITHIN COMMUNITY MENTAL HEALTH

Source - Another student's paper Compliance to psychotropic medications within community mental health

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx LÓPEZ-MUÑOZ, F., SHEN, W

Source - Another student's paper López-Muñoz, F., Shen, W

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx W., D’OCON, P., ROMERO, A., & ÁLAMO, C

Source - Another student's paper W., D’ocon, P., Romero, A., & Álamo, C

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx A HISTORY OF THE PHARMACOLOGICAL TREATMENT OF BIPOLAR DISORDER

Source - Another student's paper A history of the pharmacological treatment of bipolar disorder

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 19(7), 2143

Source - Another student's paper International journal of molecular sciences, 19(7), 2143

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx S., GESSLER, D., & OUTHRED, T

Source - Another student's paper S., Gessler, D., & Outhred, T

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx THE USE OF LITHIUM FOR THE TREATMENT OF BIPOLAR DISORDER

Source - Another student's paper The use of lithium for the treatment of bipolar disorder

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx RECOMMENDATIONS FROM CLINICAL PRACTICE GUIDELINES

Source - Another student's paper recommendations from clinical practice guidelines

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx JOURNAL OF AFFECTIVE DISORDERS, 217, 266-280

Source - Another student's paper Journal of affective disorders, 217, 266-280

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx TONDO, L., ABRAMOWICZ, M., ALDA, M., BAUER, M., BOCCHETTA, A., BOLZANI, L.,

Source - Another student's paper Tondo, L., Abramowicz, M., Alda, M., Bauer, M., Bocchetta, A., Bolzani, L.,

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx LONG-TERM LITHIUM TREATMENT IN BIPOLAR DISORDER

Source - Another student's paper Long-term lithium treatment in bipolar disorder

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx EFFECTS ON GLOMERULAR FILTRATION RATE AND OTHER METABOLIC PARAMETERS

Source - Another student's paper effects on glomerular filtration rate and other metabolic parameters

Suspected Entry: 100% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 5(1), 1-12

Source - Another student's paper International journal of bipolar disorders, 5(1), 1-12

Suspected Entry: 94% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx SHE ALSO TESTED POSITIVE FOR CYP2D6 10 ALLELE

Source - Another student's paper She tested positive for CYP2D6*10 allele

Suspected Entry: 80% match

Uploaded - WK5 AssgnMoiseM(NURS6630)Bipolar Disorder.docx WHEN GIVEN THE YOUNG MANIA RATING SCALE, HER SCORE WAS 22

Source - Another student's paper The Young Mania Rating Scale score is 22